Tox21_300970

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

4 Suppliers, 1 USDMF, 1 EU WC, 1 NDC API, 2 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports

DOSSIERs // Finished Dosage Forms

2 Dossiers, 2 FDA Orange Book

RELATED EXCIPIENT COMPANIES

Suppliers, 3 Actylis, 2 Nanjing Well Pharmaceutical, 2 Finar, 1 BASF, 1 Kerry

EXCIPIENTS BY APPLICATIONS

4 Topical, 4 Parenteral, 2 Film Formers & Plasticizers, 2 Solubilizers, 1 Controlled & Modified Release, 1 Thickeners and Stabilizers, 1 Fillers, Diluents & Binders, 1 Coating Systems & Additives

MARKET PLACE

1 APIs

1 APIs

ANALYTICAL SOLUTION(s)

1 USP Standards, 1 Other Ref. Standards

List of All Manufacturers & Suppliers of Tox21_300970 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Tox21_300970

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

4 Suppliers

1 USDMF

1 EU WC

1 NDC API

2 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

DOSSIERs // Finished Dosage Forms

2 Dossiers

2 FDA Orange Book

RELATED EXCIPIENT COMPANIES

Suppliers

3 Actylis

2 Nanjing Well Pharmaceutical

2 Finar

1 BASF

1 Kerry

EXCIPIENTS BY APPLICATIONS

4 Topical

4 Parenteral

2 Film Formers & Plasticizers

2 Solubilizers

1 Controlled & Modified Release

1 Thickeners and Stabilizers

1 Fillers, Diluents & Binders

1 Coating Systems & Additives

MARKET PLACE

1 APIs

ANALYTICAL SOLUTION(s)

1 USP Standards

1 Other Ref. Standards

Tox21_300970

Merck & Co

THIABENDAZOLE

TABLET, CHEWABLE;ORAL

500MG

1982-01-01

MINTEZOL

16096

DISCN

USA

Merck & Co

THIABENDAZOLE

SUSPENSION;ORAL

500MG/5ML

1982-01-01

MINTEZOL

16097

DISCN

USA